165 related articles for article (PubMed ID: 9478921)
1. Molecular cloning and characterization of p56dok-2 defines a new family of RasGAP-binding proteins.
Di Cristofano A; Carpino N; Dunant N; Friedland G; Kobayashi R; Strife A; Wisniewski D; Clarkson B; Pandolfi PP; Resh MD
J Biol Chem; 1998 Feb; 273(9):4827-30. PubMed ID: 9478921
[TBL] [Abstract][Full Text] [Related]
2. p62(dok): a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells.
Carpino N; Wisniewski D; Strife A; Marshak D; Kobayashi R; Stillman B; Clarkson B
Cell; 1997 Jan; 88(2):197-204. PubMed ID: 9008160
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine phosphorylation of p62dok by p210bcr-abl inhibits RasGAP activity.
Kashige N; Carpino N; Kobayashi R
Proc Natl Acad Sci U S A; 2000 Feb; 97(5):2093-8. PubMed ID: 10688886
[TBL] [Abstract][Full Text] [Related]
4. Interactions of p62(dok) with p210(bcr-abl) and Bcr-Abl-associated proteins.
Bhat A; Johnson KJ; Oda T; Corbin AS; Druker BJ
J Biol Chem; 1998 Nov; 273(48):32360-8. PubMed ID: 9822717
[TBL] [Abstract][Full Text] [Related]
5. Role of Dok-1 and Dok-2 in leukemia suppression.
Niki M; Di Cristofano A; Zhao M; Honda H; Hirai H; Van Aelst L; Cordon-Cardo C; Pandolfi PP
J Exp Med; 2004 Dec; 200(12):1689-95. PubMed ID: 15611295
[TBL] [Abstract][Full Text] [Related]
6. p62(dok), a negative regulator of Ras and mitogen-activated protein kinase (MAPK) activity, opposes leukemogenesis by p210(bcr-abl).
Di Cristofano A; Niki M; Zhao M; Karnell FG; Clarkson B; Pear WS; Van Aelst L; Pandolfi PP
J Exp Med; 2001 Aug; 194(3):275-84. PubMed ID: 11489947
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a novel member of the DOK family that binds and modulates Abl signaling.
Cong F; Yuan B; Goff SP
Mol Cell Biol; 1999 Dec; 19(12):8314-25. PubMed ID: 10567556
[TBL] [Abstract][Full Text] [Related]
8. Role of Dok-1 and Dok-2 in myeloid homeostasis and suppression of leukemia.
Yasuda T; Shirakata M; Iwama A; Ishii A; Ebihara Y; Osawa M; Honda K; Shinohara H; Sudo K; Tsuji K; Nakauchi H; Iwakura Y; Hirai H; Oda H; Yamamoto T; Yamanashi Y
J Exp Med; 2004 Dec; 200(12):1681-7. PubMed ID: 15611294
[TBL] [Abstract][Full Text] [Related]
9. Identification of the Abl- and rasGAP-associated 62 kDa protein as a docking protein, Dok.
Yamanashi Y; Baltimore D
Cell; 1997 Jan; 88(2):205-11. PubMed ID: 9008161
[TBL] [Abstract][Full Text] [Related]
10. Independent SH2-binding sites mediate interaction of Dok-related protein with RasGTPase-activating protein and Nck.
Lock P; Casagranda F; Dunn AR
J Biol Chem; 1999 Aug; 274(32):22775-84. PubMed ID: 10428862
[TBL] [Abstract][Full Text] [Related]
11. The Tek/Tie2 receptor signals through a novel Dok-related docking protein, Dok-R.
Jones N; Dumont DJ
Oncogene; 1998 Sep; 17(9):1097-108. PubMed ID: 9764820
[TBL] [Abstract][Full Text] [Related]
12. Evidence that Llck-mediated phosphorylation of p56dok and p62dok may play a role in CD2 signaling.
Némorin JG; Duplay P
J Biol Chem; 2000 May; 275(19):14590-7. PubMed ID: 10799545
[TBL] [Abstract][Full Text] [Related]
13. A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells.
Wisniewski D; Strife A; Swendeman S; Erdjument-Bromage H; Geromanos S; Kavanaugh WM; Tempst P; Clarkson B
Blood; 1999 Apr; 93(8):2707-20. PubMed ID: 10194451
[TBL] [Abstract][Full Text] [Related]
14. Protein tyrosine phosphatase 1B antagonizes signalling by oncoprotein tyrosine kinase p210 bcr-abl in vivo.
LaMontagne KR; Flint AJ; Franza BR; Pandergast AM; Tonks NK
Mol Cell Biol; 1998 May; 18(5):2965-75. PubMed ID: 9566916
[TBL] [Abstract][Full Text] [Related]
15. Novel p62dok family members, dok-4 and dok-5, are substrates of the c-Ret receptor tyrosine kinase and mediate neuronal differentiation.
Grimm J; Sachs M; Britsch S; Di Cesare S; Schwarz-Romond T; Alitalo K; Birchmeier W
J Cell Biol; 2001 Jul; 154(2):345-54. PubMed ID: 11470823
[TBL] [Abstract][Full Text] [Related]
16. Association of phosphatidylinositol 3-kinase with SHC in chronic myelogeneous leukemia cells.
Harrison-Findik D; Susa M; Varticovski L
Oncogene; 1995 Apr; 10(7):1385-91. PubMed ID: 7537361
[TBL] [Abstract][Full Text] [Related]
17. Quantification of change in phosphorylation of BCR-ABL kinase and its substrates in response to Imatinib treatment in human chronic myelogenous leukemia cells.
Liang X; Hajivandi M; Veach D; Wisniewski D; Clarkson B; Resh MD; Pope RM
Proteomics; 2006 Aug; 6(16):4554-64. PubMed ID: 16858728
[TBL] [Abstract][Full Text] [Related]
18. Pleckstrin homology and phosphotyrosine-binding domain-dependent membrane association and tyrosine phosphorylation of Dok-4, an inhibitory adapter molecule expressed in epithelial cells.
Bedirian A; Baldwin C; Abe J; Takano T; Lemay S
J Biol Chem; 2004 Apr; 279(18):19335-49. PubMed ID: 14963042
[TBL] [Abstract][Full Text] [Related]
19. Functional interaction of RasGAP-binding proteins Dok-1 and Dok-2 with the Tec protein tyrosine kinase.
Gérard A; Favre C; Garçon F; Némorin JG; Duplay P; Pastor S; Collette Y; Olive D; Nunès JA
Oncogene; 2004 Feb; 23(8):1594-8. PubMed ID: 14647425
[TBL] [Abstract][Full Text] [Related]
20. Recruitment of Dok-R to the EGF receptor through its PTB domain is required for attenuation of Erk MAP kinase activation.
Jones N; Dumont DJ
Curr Biol; 1999 Sep; 9(18):1057-60. PubMed ID: 10508618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
